rs7051368

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_194277.3(FRMD7):​c.1101T>C​(p.Asn367Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0889 in 1,205,850 control chromosomes in the GnomAD database, including 3,561 homozygotes. There are 33,772 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 318 hom., 2541 hem., cov: 22)
Exomes 𝑓: 0.089 ( 3243 hom. 31231 hem. )

Consequence

FRMD7
NM_194277.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.160

Publications

2 publications found
Variant links:
Genes affected
FRMD7 (HGNC:8079): (FERM domain containing 7) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of neuron projection development. Predicted to act upstream of or within several processes, including negative regulation of stress fiber assembly; positive regulation of lamellipodium assembly; and positive regulation of small GTPase mediated signal transduction. Located in cytosol; nucleoplasm; and plasma membrane. Implicated in congenital nystagmus 1. [provided by Alliance of Genome Resources, Apr 2022]
FRMD7 Gene-Disease associations (from GenCC):
  • nystagmus 1, congenital, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-132078916-A-G is Benign according to our data. Variant chrX-132078916-A-G is described in ClinVar as Benign. ClinVar VariationId is 263086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.16 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0959 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRMD7NM_194277.3 linkc.1101T>C p.Asn367Asn synonymous_variant Exon 12 of 12 ENST00000298542.9 NP_919253.1 Q6ZUT3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRMD7ENST00000298542.9 linkc.1101T>C p.Asn367Asn synonymous_variant Exon 12 of 12 1 NM_194277.3 ENSP00000298542.3 Q6ZUT3-1
FRMD7ENST00000464296.1 linkc.1056T>C p.Asn352Asn synonymous_variant Exon 12 of 12 1 ENSP00000417996.1 Q6ZUT3-2
FRMD7ENST00000370879.5 linkc.741T>C p.Asn247Asn synonymous_variant Exon 8 of 8 1 ENSP00000359916.1 X6R7S7

Frequencies

GnomAD3 genomes
AF:
0.0856
AC:
9517
AN:
111142
Hom.:
317
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0916
Gnomad AMI
AF:
0.0220
Gnomad AMR
AF:
0.0599
Gnomad ASJ
AF:
0.0523
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0150
Gnomad FIN
AF:
0.0906
Gnomad MID
AF:
0.0987
Gnomad NFE
AF:
0.0982
Gnomad OTH
AF:
0.0927
GnomAD2 exomes
AF:
0.0688
AC:
12461
AN:
181051
AF XY:
0.0666
show subpopulations
Gnomad AFR exome
AF:
0.0938
Gnomad AMR exome
AF:
0.0372
Gnomad ASJ exome
AF:
0.0494
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0836
Gnomad NFE exome
AF:
0.0985
Gnomad OTH exome
AF:
0.0781
GnomAD4 exome
AF:
0.0892
AC:
97648
AN:
1094652
Hom.:
3243
Cov.:
30
AF XY:
0.0867
AC XY:
31231
AN XY:
360286
show subpopulations
African (AFR)
AF:
0.0980
AC:
2581
AN:
26339
American (AMR)
AF:
0.0399
AC:
1404
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.0519
AC:
1005
AN:
19367
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30188
South Asian (SAS)
AF:
0.0163
AC:
882
AN:
54060
European-Finnish (FIN)
AF:
0.0841
AC:
3405
AN:
40493
Middle Eastern (MID)
AF:
0.111
AC:
457
AN:
4119
European-Non Finnish (NFE)
AF:
0.100
AC:
84073
AN:
838902
Other (OTH)
AF:
0.0835
AC:
3840
AN:
45980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
3208
6416
9624
12832
16040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3080
6160
9240
12320
15400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0857
AC:
9527
AN:
111198
Hom.:
318
Cov.:
22
AF XY:
0.0760
AC XY:
2541
AN XY:
33432
show subpopulations
African (AFR)
AF:
0.0918
AC:
2809
AN:
30597
American (AMR)
AF:
0.0598
AC:
625
AN:
10448
Ashkenazi Jewish (ASJ)
AF:
0.0523
AC:
138
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3514
South Asian (SAS)
AF:
0.0143
AC:
38
AN:
2657
European-Finnish (FIN)
AF:
0.0906
AC:
537
AN:
5929
Middle Eastern (MID)
AF:
0.107
AC:
23
AN:
214
European-Non Finnish (NFE)
AF:
0.0982
AC:
5203
AN:
52999
Other (OTH)
AF:
0.0916
AC:
139
AN:
1518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
319
638
956
1275
1594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0912
Hom.:
4553
Bravo
AF:
0.0845
EpiCase
AF:
0.0990
EpiControl
AF:
0.0990

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nystagmus 1, congenital, X-linked Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
0.68
DANN
Benign
0.63
PhyloP100
0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7051368; hg19: chrX-131212944; COSMIC: COSV53745461; COSMIC: COSV53745461; API